Clinical Trials · NCT02972645
A Study of LY3305677 in Healthy Participants
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 66
- Start date
- Dec 2016
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Number of Participants with One or More Serious Adverse Event(s) (SAEs) considered by the Investigator to be Related to Study Drug Administration